صورة الغلاف

Advanced Prostate Adenocarcinoma and Androgen Deprivation Therapy. Clinical Outcomes, Risk Stratification, and Therapeutic Results

Advanced prostate adenocarcinoma presents intricate clinical challenges shaped by biological heterogeneity and evolving therapeutic demands. This volume examines patients treated with total androgen deprivation therapy in a tertiary-care hospital between 2017 and 2020, offering an observational pers...

وصف كامل

محفوظ في:
التنسيق: Online
اللغة:الإنجليزية
منشور في: South American Publishing 2026
الموضوعات:
Prostate cancer, Advanced prostate adenocarcinoma, Androgen deprivation therapy, Risk stratification, Prostate-specific antigen, Hormonal resistance
thema EDItEUR::V Health, Relationships and Personal development::VF Family and health::VFD Popular medicine and health::VFDM Men’s health::VFDM1 Prostate health
thema EDItEUR::M Medicine and Nursing
الوصول للمادة أونلاين:https://directory.doabooks.org/handle/20.500.12854/176897
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
الملخص:Advanced prostate adenocarcinoma presents intricate clinical challenges shaped by biological heterogeneity and evolving therapeutic demands. This volume examines patients treated with total androgen deprivation therapy in a tertiary-care hospital between 2017 and 2020, offering an observational perspective on risk stratification, biochemical response, and disease progression. Particular attention is given to prostate-specific antigen dynamics, serum testosterone levels, and the broader physiological consequences of hormonal suppression, including effects on sexual function and general health. By situating clinical findings within tumor biology and institutional practice, the study provides a grounded account of treatment monitoring and outcome interpretation in advanced prostate cancer care.

مواد مشابهة